Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure
QL reduces the levels of plasma AngII and renal AT1R expression in CHF rats. (a) AngII levels in plasma were elevated in CHF rats; treatment with QL and Valsartan decreased AngII levels in plasma. (b) Renal AT1R protein increased in CHF rats, treatment with QL and Valsartan attenuated renal AT1R protein in CHF rats. (, versus the CHF group, , versus the sham group).